Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | CNR1 | P21554 | 1/20 | 0.48 |
| ▸ | MMP2 | P08253 | 1/20 | 0.47 |
| ▸ | MMP8 | P22894 | 2/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | PLAAT5 | Q96KN8 | 3/20 | 0.46 |
| ▸ | PLAAT4 | Q9UL19 | 3/20 | 0.46 |
| ▸ | PLAAT3 | P53816 | 2/20 | 0.46 |
| ▸ | PLAAT2 | Q9NWW9 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6380920 | 0.99 | HDAC8 (0.48) | CYP2D6CYP2C9CYP2C19KMT2ACNR1 | |
| SCHEMBL7416564 | 0.88 | MMP2 (0.48) | MMP2MMP8 | |
| SCHEMBL7530381 | 0.88 | MMP2 (0.48) | MMP2MMP8 | |
| SCHEMBL7530376 | 0.88 | MMP2 (0.48) | MMP2MMP8 | |
| Homophenylalanine SCHEMBL20957448 | 0.85 | GRIK1 (0.48) | CYP2D6CYP2C9CYP2C19KMT2ACNR1 | |
| SCHEMBL27118430 | 0.84 | MMP2 (0.50) | MMP2 | |
| SCHEMBL22674667 | 0.84 | NPY4R (0.51) | KMT2AMMP8 | |
| SCHEMBL14444028 | 0.83 | POLB (0.55) | CYP2D6CYP2C9CYP2C19KMT2AMMP2 | |
| SCHEMBL30889119 | 0.82 | MMP2 (0.67) | CYP2D6CYP2C9CYP2C19KMT2AMMP2 | |
| SCHEMBL20257410 | 0.82 | ALPI (0.50) | HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4363433-B1 | PEPTIDE SYNTHESIS METHOD INVOLVING STERICALLY HINDERED MIXED ANHYDRIDE INTERMEDIATE | AMICOAT AS (NO) | 2025-10-08 | — | — | EP | disclosed |
| US-20240174713-A1 | PEPTIDE SYNTHESIS METHOD INVOLVING STERICALLY HINDERED MIXED ANHYDRIDE INTERMEDIATE | PHARMA HOLDINGS AS (NO) | 2024-05-30 | — | — | US | disclosed |
| US-20230338609-A1 | MEDICAL DEVICES AND MATERIALS COMPRISING BIODEGRADABLE POLYESTERS | AMICOAT AS (NO) | 2023-10-26 | — | — | US | disclosed |
| WO-2023275410-A1 | PEPTIDE SYNTHESIS METHOD INVOLVING STERICALLY HINDERED MIXED ANHYDRIDE INTERMEDIATE | AMICOAT AS (NO) | 2023-01-05 | — | — | WO | disclosed |
| WO-2002024192-A1 | DIPEPTIDE LIGANDS OF THE NPFF RECEPTOR FOR TREATING PAIN AND HYPERALGESIA | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) | 2002-03-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240174713-A1 | PEPTIDE SYNTHESIS METHOD INVOLVING STERICALLY HINDERED MIXED ANHYDRIDE INTERMEDIATE | VIP, GRPR, SSTR4 | CYP2D6 3855/4885CYP2C9 4023/4885CYP2C19 3425/4885 |
| US-20230338609-A1 | MEDICAL DEVICES AND MATERIALS COMPRISING BIODEGRADABLE POLYESTERS | AGXT, ECPAS, MLX | CYP2D6 1297/4885CYP2C9 166/4885CYP2C19 80/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.